GoodRx Quarterly Balance Sheets Chart
Quarterly
|
Annual
GoodRx Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||
| current assets | ||||||||||||||||||||
| cash and cash equivalents | 281,318,000 | 300,981,000 | 448,346,000 | 423,777,000 | 524,903,000 | 533,295,000 | 672,296,000 | 794,905,000 | 761,988,000 | 761,075,000 | 757,165,000 | 728,786,000 | 730,540,000 | 845,427,000 | 941,109,000 | 912,023,000 | 894,703,000 | 990,463,000 | 968,691,000 | 1,075,024,000 |
| accounts receivable | 189,027,000 | 160,117,000 | 145,934,000 | 130,803,000 | 161,774,000 | 144,769,000 | 143,608,000 | 121,146,000 | 123,378,000 | 116,442,000 | 117,141,000 | 120,886,000 | 122,878,000 | 123,281,000 | 118,080,000 | 98,511,000 | 87,004,000 | 74,399,000 | 68,729,000 | 63,518,000 |
| prepaid expenses and other current assets | 80,269,000 | 79,110,000 | 64,975,000 | 72,220,000 | 63,878,000 | 54,735,000 | 56,886,000 | 53,047,000 | 33,886,000 | 29,499,000 | 45,380,000 | 28,716,000 | 40,539,000 | 26,015,000 | 29,638,000 | 41,006,000 | 94,043,000 | 55,618,000 | 46,048,000 | 39,630,000 |
| total current assets | 550,614,000 | 540,208,000 | 659,255,000 | 626,800,000 | 750,555,000 | 732,799,000 | 872,790,000 | 969,098,000 | 919,252,000 | 907,016,000 | 919,686,000 | 878,388,000 | 893,957,000 | 994,723,000 | 1,088,827,000 | 1,051,540,000 | 1,075,750,000 | 1,123,380,000 | 1,086,368,000 | 1,181,072,000 |
| property and equipment | 10,732,000 | 11,512,000 | 12,664,000 | 13,625,000 | 14,495,000 | 15,341,000 | 15,932,000 | 16,879,000 | 17,923,000 | 18,767,000 | 19,820,000 | 22,287,000 | 22,877,000 | 22,564,000 | 21,612,000 | 21,837,000 | 22,105,000 | 22,693,000 | 23,057,000 | 16,757,000 |
| goodwill | 421,719,000 | 421,719,000 | 410,769,000 | 410,769,000 | 410,769,000 | 410,769,000 | 410,769,000 | 412,117,000 | 412,117,000 | 412,117,000 | 412,117,000 | 415,256,000 | 415,256,000 | 334,642,000 | 329,696,000 | 329,696,000 | 320,196,000 | 261,116,000 | 261,116,000 | 261,116,000 |
| intangible assets | 65,566,000 | 68,359,000 | 52,102,000 | 54,061,000 | 56,022,000 | 58,122,000 | 60,898,000 | 89,431,000 | 108,657,000 | 114,256,000 | 119,865,000 | 125,900,000 | 131,719,000 | 85,990,000 | 88,791,000 | 94,077,000 | 94,780,000 | 34,443,000 | 36,919,000 | 39,225,000 |
| capitalized software | 138,287,000 | 130,576,000 | 124,781,000 | 119,898,000 | 111,774,000 | 103,980,000 | 95,439,000 | 91,979,000 | 93,478,000 | 83,047,000 | 70,072,000 | 71,299,000 | 61,700,000 | 52,505,000 | 44,987,000 | 39,254,000 | 31,996,000 | 25,944,000 | 19,800,000 | 15,400,000 |
| operating lease right-of-use assets | 30,692,000 | 22,898,000 | 27,794,000 | 28,842,000 | 29,893,000 | 30,928,000 | 29,929,000 | 31,501,000 | 33,538,000 | 34,916,000 | 35,906,000 | 27,971,000 | 28,507,000 | 26,978,000 | 27,705,000 | 25,969,000 | 26,902,000 | 27,883,000 | 27,712,000 | 29,318,000 |
| deferred tax assets | 77,182,000 | 77,182,000 | 77,182,000 | 65,910,000 | 65,268,000 | 65,268,000 | 65,268,000 | 57,695,000 | 62,686,000 | 45,824,000 | 12,971,000 | 13,344,000 | 13,117,000 | 1,687,000 | ||||||
| other assets | 23,914,000 | 22,817,000 | 23,520,000 | 34,941,000 | 36,614,000 | 36,756,000 | 37,775,000 | 39,272,000 | 44,451,000 | 41,381,000 | 27,165,000 | 25,958,000 | 37,980,000 | 20,926,000 | 6,007,000 | 6,168,000 | 2,229,000 | 2,171,000 | 2,025,000 | 2,230,000 |
| total assets | 1,318,706,000 | 1,295,271,000 | 1,388,067,000 | 1,354,846,000 | 1,475,390,000 | 1,453,963,000 | 1,588,800,000 | 1,707,972,000 | 1,692,102,000 | 1,611,500,000 | 1,604,631,000 | 1,567,059,000 | 1,591,996,000 | 1,538,328,000 | 1,607,625,000 | 1,614,365,000 | 1,586,929,000 | 1,510,974,000 | 1,470,114,000 | 1,546,805,000 |
| liabilities and stockholders' equity | ||||||||||||||||||||
| current liabilities | ||||||||||||||||||||
| accounts payable | 25,411,000 | 15,258,000 | 14,137,000 | 12,391,000 | 16,884,000 | 33,518,000 | 36,266,000 | 32,905,000 | 6,795,000 | 12,389,000 | 17,700,000 | 10,855,000 | 16,825,000 | 12,820,000 | 17,501,000 | 17,279,000 | 18,378,000 | 15,101,000 | 10,291,000 | 14,014,000 |
| accrued expenses and other current liabilities | 95,677,000 | 77,567,000 | 99,130,000 | 92,677,000 | 73,172,000 | 70,843,000 | 71,329,000 | 74,554,000 | 66,001,000 | 47,730,000 | 47,523,000 | 61,025,000 | 49,766,000 | 33,812,000 | 50,732,000 | 42,447,000 | 33,759,000 | 34,944,000 | 37,692,000 | 36,093,000 |
| current portion of debt | 5,000,000 | 5,000,000 | 5,000,000 | 3,750,000 | 7,029,000 | 7,029,000 | 8,787,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 | 7,029,000 |
| operating lease liabilities, current | 4,821,000 | 5,558,000 | 5,636,000 | 5,543,000 | 5,388,000 | 5,131,000 | 6,177,000 | 3,334,000 | 2,728,000 | 1,833,000 | 4,068,000 | 6,057,000 | 5,998,000 | 5,703,000 | 5,851,000 | 5,926,000 | 6,325,000 | 5,975,000 | 4,539,000 | 3,029,000 |
| total current liabilities | 130,909,000 | 103,383,000 | 123,903,000 | 114,361,000 | 102,473,000 | 116,521,000 | 122,559,000 | 117,822,000 | 82,553,000 | 68,981,000 | 76,320,000 | 84,966,000 | 79,618,000 | 59,364,000 | 81,113,000 | 72,681,000 | 65,491,000 | 63,049,000 | 59,551,000 | 60,165,000 |
| debt | 484,972,000 | 485,837,000 | 486,711,000 | 487,593,000 | 645,648,000 | 646,678,000 | 647,703,000 | 648,729,000 | 649,753,000 | 650,776,000 | 651,796,000 | 652,814,000 | 653,830,000 | 654,845,000 | 655,858,000 | 656,868,000 | 657,877,000 | 658,883,000 | 659,888,000 | 688,891,000 |
| operating lease liabilities, net of current portion | 52,745,000 | 44,794,000 | 46,040,000 | 47,681,000 | 49,316,000 | 51,339,000 | 48,403,000 | 52,387,000 | 54,858,000 | 56,278,000 | 54,131,000 | 32,551,000 | 33,600,000 | 32,512,000 | 33,592,000 | 32,033,000 | 32,818,000 | 33,705,000 | 33,467,000 | 34,424,000 |
| other liabilities | 7,049,000 | 6,910,000 | 6,755,000 | 8,777,000 | 8,554,000 | 8,356,000 | 8,177,000 | 7,761,000 | 9,567,000 | 7,997,000 | 7,557,000 | 7,675,000 | 6,553,000 | 4,703,000 | 5,138,000 | 6,387,000 | 6,349,000 | 6,278,000 | 5,849,000 | 5,144,000 |
| total liabilities | 675,675,000 | 640,924,000 | 663,409,000 | 658,412,000 | 805,991,000 | 822,894,000 | 826,842,000 | 826,699,000 | 796,731,000 | 784,032,000 | 789,804,000 | 778,656,000 | 774,056,000 | 751,821,000 | 775,945,000 | 767,969,000 | 762,535,000 | 761,915,000 | 758,755,000 | 790,396,000 |
| commitments and contingencies | ||||||||||||||||||||
| stockholders' equity | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at june 30, 2025 and december 31, 2024 | ||||||||||||||||||||
| common stock | 35,000 | 36,000 | 38,000 | 38,000 | 38,000 | 38,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 40,000 | 39,000 | 39,000 | 39,000 | ||
| additional paid-in capital | 2,060,114,000 | 2,084,272,000 | 2,165,633,000 | 2,144,149,000 | 2,121,079,000 | 2,089,443,000 | 2,219,321,000 | 2,312,767,000 | 2,288,370,000 | 2,279,253,000 | 2,263,322,000 | 2,234,926,000 | 2,222,729,000 | 2,189,881,000 | 2,247,347,000 | 2,222,150,000 | 2,182,079,000 | 2,137,805,000 | 2,101,773,000 | 1,848,549,000 |
| accumulated deficit | -1,417,118,000 | -1,429,961,000 | -1,441,013,000 | -1,447,753,000 | -1,451,718,000 | -1,458,412,000 | -1,457,403,000 | -1,431,534,000 | -1,393,039,000 | -1,451,825,000 | -1,448,535,000 | -1,446,563,000 | -1,404,829,000 | -1,403,414,000 | -1,415,707,000 | -1,375,793,000 | -1,357,724,000 | -1,388,785,000 | -1,390,453,000 | -1,092,179,000 |
| total stockholders' equity | 643,031,000 | 654,347,000 | 724,658,000 | 696,434,000 | 669,399,000 | 631,069,000 | 761,958,000 | 881,273,000 | 895,371,000 | 827,468,000 | 814,827,000 | 788,403,000 | 817,940,000 | 786,507,000 | 831,680,000 | 846,396,000 | 824,394,000 | 749,059,000 | 711,359,000 | 756,409,000 |
| total liabilities and stockholders' equity | 1,318,706,000 | 1,295,271,000 | 1,388,067,000 | 1,354,846,000 | 1,475,390,000 | 1,453,963,000 | 1,588,800,000 | 1,707,972,000 | 1,692,102,000 | 1,611,500,000 | 1,604,631,000 | 1,567,059,000 | 1,591,996,000 | 1,538,328,000 | 1,607,625,000 | 1,614,365,000 | 1,586,929,000 | 1,510,974,000 | ||
| preferred stock, 0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at march 31, 2025 and december 31, 2024 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at december 31, 2024 and december 31, 2023 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at september 30, 2024 and december 31, 2023 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at december 31, 2023 and december 31, 2022 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at december 31, 2022 and december 31, 2021 | ||||||||||||||||||||
| deferred tax liabilities | 650,000 | 455,000 | 397,000 | 244,000 | 1,772,000 | |||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||
| restricted cash | 2,900,000 | 2,900,000 | 2,900,000 | |||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at december 31, 2021 and december 31, 2020 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||
| liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||||||||||||
| redeemable convertible preferred stock | ||||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 and zero shares authorized at december 31, 2020 and december 31, 2019, respectively; and zero shares issued and outstanding at december 31, 2020 and december 31, 2019 | ||||||||||||||||||||
| total liabilities, redeemable convertible preferred stock and stockholders' equity | 1,470,114,000 | 1,546,805,000 | ||||||||||||||||||
| preferred stock, 0.0001 par value; 50,000 and zero shares authorized at september 30, 2020 and december 31, 2019, respectively; and zero shares issued and outstanding at september 30, 2020 and december 31, 2019 |
We provide you with 20 years of balance sheets for GoodRx stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GoodRx. Explore the full financial landscape of GoodRx stock with our expertly curated balance sheets.
The information provided in this report about GoodRx stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.